波音游戏-波音娱乐城赌球打不开

Mapping a biotech future in Hong Kong

Regina Lau

 

Recent biotech achievements in China offer immense opportunities for Hong Kong to enhance her position in biotechnology, one of the most promising industries for coming decades, said Professor Y L Lo, Founding Chairman of the Hong Kong Biotechnology Association, at CityU on 20 January. Professor Lo's lecture, "Biotechnology-the Catalyst of Hong Kong's Future Economic Development?" was the latest in the Distinguished Industrialist Lecture Series, organized by CityU's Faculty of Science and Engineering to foster closer links between the University community and the business sector. "Collaborating with China and participation in i

nternational biotech projects are crucial steps for Hong Kong to establish itself in this mega trend for the 21st century," he told the audience.

Professor Lo, who is also the President (Asia Pacific) of PerkinElmer Life and Sciences (Hong Kong) Limited, a US based biotech company, gave a comprehensive picture of biotech development in the Asia Pacific region, which is set to become the engine for global economic growth. Governments in Taiwan, Korea, Singapore and Japan have shown a clear commitment to expanding the biotech industry, which has also experienced booming investment from the private sector. With her growing contributions to the Human Genome Project, breakthroughs in decoding the hybrid rice genome, and production of recombinant drugs and vaccines, China is capable of becoming a future leader in the Asia biotech industry, he said.

"In Hong Kong, the biotech industry is currently very much trade-based. We are lagging behind our neighbors in terms of technological innovation and R&D investment," said Professor Lo. "But with a strong service base, heightened awareness among our entrepreneurs of the huge potential of the life science industry, and our position as China's bridge to the world, Hong Kong is well situated to find a niche in the booming biotech field."

The process of commercialization and technology transfer in biotechnology creates huge opportunities for various sectors, including the legal and fina

nce sectors. Instead of starting from scratch, Hong Kong should focus on the advanced stages of the process, Professor Lo said. "Immense opportunities in servicing and intellectual property protection at the advanced stage of the process are waiting to be explored." 

 

你可能感興趣

聯(lián)絡(luò)資料

傳訊及數(shù)據(jù)研究處

Back to top
茅台百家乐官网的玩法技巧和规则| 百家乐游戏真钱游戏| 百家乐官网博彩平台| 大发888博彩论坛贴吧| 澳门百家乐娱乐开户| 362百家乐官网的玩法技巧和规则 大集汇百家乐官网的玩法技巧和规则 | 澳门百家乐官网官方网址| 久盛| 必胜娱乐场| 威尼斯人娱乐城排名| 百家乐板路| 澳门百家乐娱乐场开户注册| 百家乐庄闲和赢率| 网络百家乐的玩法技巧和规则 | 明升百家乐娱乐城| 百家乐最新打法| 2024年九运的房屋风水吉凶| 百家乐赌王有哪些| 澳门百家乐先赢后输| 百家乐网上投注系统| 发中发百家乐官网的玩法技巧和规则| 百家乐官网注码技术打法| 百家乐官网天下第一庄| 杭州百家乐官网西园| 速博百家乐官网的玩法技巧和规则| 皇冠百家乐官网客户端皇冠| 哪个百家乐官网投注平台信誉好 | 张家港百家乐官网赌博| 百家乐官网博娱乐平台| 尊龙百家乐官网娱乐场开户注册| 百家乐官网赌博软件下载| 2024九紫离火| 百家乐赌缆十三式| 百家乐好不好| 金都娱乐| 百家乐官网娱乐城新闻| 缅甸百家乐官网网络赌博解谜| 金都百家乐官网的玩法技巧和规则| 网上百家乐官网真钱游戏| 百家乐赌场牌路分析| 大发888国际娱乐城lm0|